{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:55:42Z","timestamp":1757310942587},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":3142,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1038\/sj.mt.6300390","type":"journal-article","created":{"date-parts":[[2008,1,8]],"date-time":"2008-01-08T10:02:54Z","timestamp":1199786574000},"page":"607-617","source":"Crossref","is-referenced-by-count":21,"title":["Tumor Protection Following Vaccination With Low Doses of Lentivirally Transduced DCs Expressing the Self-antigen erbB2"],"prefix":"10.1016","volume":"16","author":[{"given":"Miriam E","family":"Mossoba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagdeep S","family":"Walia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa I","family":"Rasaiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Buxhoeveden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renee","family":"Head","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuyan","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason E","family":"Foley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan L","family":"Bramson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel H","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A","family":"Medin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/sj.mt.6300390_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/14653240410005230","article-title":"Loading DCs with Ag","volume":"6","author":"Vari","year":"2004","journal-title":"Cytotherapy"},{"key":"10.1038\/sj.mt.6300390_bib2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/01.cji.0000171292.79663.cb","article-title":"Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon","volume":"28","author":"Banchereau","year":"2005","journal-title":"J Immunother"},{"key":"10.1038\/sj.mt.6300390_bib3","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/01.cji.0000171291.72039.e2","article-title":"Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial","volume":"28","author":"Lee","year":"2005","journal-title":"J Immunother"},{"key":"10.1038\/sj.mt.6300390_bib4","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/annonc\/mdl072","article-title":"Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests","volume":"17","author":"Lesterhuis","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1038\/sj.mt.6300390_bib5","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1158\/1078-0432.CCR-03-0430","article-title":"Generation of carcinoembryonic antigen (CEA)-specific T-cell responses in HLA-A*0201 and HLA-A*2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides","volume":"10","author":"Liu","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1038\/sj.mt.6300390_bib6","first-page":"1028","article-title":"Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells","volume":"60","author":"Boczkowski","year":"2000","journal-title":"Cancer Res"},{"key":"10.1038\/sj.mt.6300390_bib7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1084\/jem.184.2.465","article-title":"Dendritic cells pulsed with RNA are potent antigen-presenting cells, in vitro and in vivo","volume":"184","author":"Boczkowski","year":"1996","journal-title":"J Exp Med"},{"key":"10.1038\/sj.mt.6300390_bib8","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nbt0498-364","article-title":"Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic Tlymphocytes, in vitro using human dendritic cells transfected with RNA","volume":"16","author":"Nair","year":"1998","journal-title":"Nat Biotechnol"},{"key":"10.1038\/sj.mt.6300390_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00002371-200207000-00001","article-title":"Current methods for loading dendritic cells with tumor antigen for the induction of antitumor immunity","volume":"25","author":"Zhou","year":"2002","journal-title":"J Immunother"},{"key":"10.1038\/sj.mt.6300390_bib10","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.4049\/jimmunol.174.6.3808","article-title":"Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity","volume":"174","author":"He","year":"2005","journal-title":"J Immunol"},{"key":"10.1038\/sj.mt.6300390_bib11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.immuni.2006.03.014","article-title":"Skin-derived dendritic cells induce potent CD8+ T cell immunity in recombinant lentivector-mediated genetic immunization","volume":"24","author":"He","year":"2006","journal-title":"Immunity"},{"key":"10.1038\/sj.mt.6300390_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jgm.243","article-title":"Use of a lentiviral flap vector for induction of CTL immunity against melanoma. Perspectives for immunotherapy","volume":"4","author":"Firat","year":"2002","journal-title":"J Gene Med"},{"key":"10.1038\/sj.mt.6300390_bib13","first-page":"654","article-title":"Lentivirally transduced dendritic cells as a tool for cancer immunotherapy","volume":"5","author":"Breckpot","year":"2003","journal-title":"JGene Med"},{"key":"10.1038\/sj.mt.6300390_bib14","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1089\/10430340152710540","article-title":"Lentiviral vector-mediated tyrosinase-related protein 2 gene transfer to dendritic cells for the therapy of melanoma","volume":"12","author":"Metharom","year":"2001","journal-title":"Hum Gene Ther"},{"key":"10.1038\/sj.mt.6300390_bib15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1586\/14760584.5.5.717","article-title":"Cancer immunotherapy using virally-transduced DCs: a review of animal studies and human clinical trials","volume":"5","author":"Mossoba","year":"2006","journal-title":"Expert Rev Vaccines"},{"key":"10.1038\/sj.mt.6300390_bib16","first-page":"2643","article-title":"HER-2\/neu (p185neu) protein expression in the natural or treated history of prostate cancer","volume":"7","author":"Osman","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1038\/sj.mt.6300390_bib17","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1200\/JCO.1999.17.9.2639","article-title":"Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease","volume":"17","author":"Cobleigh","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1038\/sj.mt.6300390_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/sonc.2002.31523","article-title":"HER2\/neu expression in malignant lung tumors","volume":"29","author":"Hirsch","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1038\/sj.mt.6300390_bib19","first-page":"2420","article-title":"Overexpression of HER-2 in ovarian carcinomas","volume":"61","author":"Hellstrom","year":"2001","journal-title":"Cancer Res"},{"key":"10.1038\/sj.mt.6300390_bib20","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1128\/MCB.13.4.2247","article-title":"A truncated intracellular HER2\/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells","volume":"13","author":"Scott","year":"1993","journal-title":"Mol Cell Biol"},{"key":"10.1038\/sj.mt.6300390_bib21","doi-asserted-by":"crossref","first-page":"16909","DOI":"10.1073\/pnas.0407572101","article-title":"Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors","volume":"101","author":"Yoshimitsu","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.mt.6300390_bib22","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1006\/mthe.2001.0298","article-title":"Enhanced therapeutic effect of HSV-tk+GCV gene therapy and ionizing radiation for prostate cancer","volume":"3","author":"Chhikara","year":"2001","journal-title":"Mol Ther"},{"key":"10.1038\/sj.mt.6300390_bib23","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/sj.cgt.7700810","article-title":"Efficient transfer of PSA and PSMA cDNAs into DCs generates antibody and T cell antitumor responses, in vivo","volume":"12","author":"Medin","year":"2005","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/sj.mt.6300390_bib24","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ymthe.2004.07.017","article-title":"Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: implications for cancer immunotherapy protocols","volume":"10","author":"Dullaers","year":"2004","journal-title":"Mol Ther"},{"key":"10.1038\/sj.mt.6300390_bib25","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ymthe.2006.05.014","article-title":"In vivo gene transfer into adult stem cells in unconditioned mice by in situ delivery of a lentiviral vector","volume":"14","author":"Worsham","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/sj.mt.6300390_bib26","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/sj.mt.6300083","article-title":"Importance of murine study design for testing toxicity of retroviral vectors in support of phase I trials","volume":"15","author":"Will","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/sj.mt.6300390_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ymthe.2005.01.019","article-title":"Intrapulmonary and intramyocardial gene transfer in rhesus monkeys (Macaca mulatta): safety and efficiency of HIV-1-derived lentiviral vectors for fetal gene delivery","volume":"12","author":"Tarantal","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/sj.mt.6300390_bib28","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.0608138103","article-title":"Genetransfer in humans using a conditionally replicating lentiviral vector","volume":"103","author":"Levine","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.mt.6300390_bib29","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/sj.gt.3302797","article-title":"HER-2\/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2\/neu-specific immune responses compared to DNA vaccination","volume":"13","author":"Chan","year":"2006","journal-title":"Gene Ther"},{"key":"10.1038\/sj.mt.6300390_bib30","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/sj.cgt.7700498","article-title":"Enhanced HER-2\/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2\/neu and \u03b1 tumor necrosis factor","volume":"9","author":"Chen","year":"2002","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/sj.mt.6300390_bib31","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1158\/0008-5472.CAN-03-3442","article-title":"Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice","volume":"64","author":"Sakai","year":"2004","journal-title":"Cancer Res"},{"key":"10.1038\/sj.mt.6300390_bib32","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.4049\/jimmunol.167.3.1712","article-title":"The generation of both T killer and Th cell clones specific for the tumor-associated antigen HER2 using retrovirally transduced dendritic cells","volume":"167","author":"zum B\u00fcschenfelde","year":"2001","journal-title":"J Immunol"},{"key":"10.1038\/sj.mt.6300390_bib33","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1182\/blood-2004-06-2416","article-title":"Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells","volume":"105","author":"Garnache-Ottou","year":"2005","journal-title":"Blood"},{"key":"10.1038\/sj.mt.6300390_bib34","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/sj.leu.2404480","article-title":"Acute differentiated dendritic cell leukemia: a variant form of pediatric acute myeloid leukemia with MLL translocation","volume":"21","author":"Nigro","year":"2007","journal-title":"Leukemia"},{"key":"10.1038\/sj.mt.6300390_bib35","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1097\/01.pas.0000172194.32918.5c","article-title":"CD4+ CD56+ lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells","volume":"29","author":"Reichard","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/sj.mt.6300390_bib36","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/10428190500353216","article-title":"Acute leukemia of dendritic cell lineage in childhood: incidence, biological characteristics and outcome","volume":"47","author":"Rossi","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1038\/sj.mt.6300390_bib37","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2141.2006.06458.x","article-title":"Plasmacytoid dendritic cell leukaemia\/lymphoma: towards a well defined entity?","volume":"136","author":"Garnache-Ottou","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1038\/sj.mt.6300390_bib38","first-page":"58","article-title":"Incidence and characteristics of CD4+\/HLA DRhi dendritic cell malignancies","volume":"89","author":"Bueno","year":"2004","journal-title":"Haematologica"},{"key":"10.1038\/sj.mt.6300390_bib39","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/mt.sj.6300122","article-title":"Engineered human tmpk\/AZT as a novel enzyme\/prodrug axis for suicide gene therapy","volume":"15","author":"Sato","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/sj.mt.6300390_bib40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/sj.gt.3302407","article-title":"Ex vivo generation of genetically modified dendritic cells for immunotherapy: implications of lymphocyte contamination","volume":"12","author":"Chinnasamy","year":"2005","journal-title":"Gene Ther"},{"key":"10.1038\/sj.mt.6300390_bib41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","article-title":"Anadvanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow","volume":"223","author":"Lutz","year":"1999","journal-title":"J Immunol Methods"},{"key":"10.1038\/sj.mt.6300390_bib42","article-title":"Expression mapping of mouse genes","author":"Freeman","year":"1998","journal-title":"MGI Direct Data Submission"},{"key":"10.1038\/sj.mt.6300390_bib43","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4049\/jimmunol.160.2.643","article-title":"Activation of low avidity CTL specific for a self epitope results in tumor rejection but not autoimmunity","volume":"160","author":"Morgan","year":"1998","journal-title":"J Immunol"},{"key":"10.1038\/sj.mt.6300390_bib44","first-page":"6995","article-title":"Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model","volume":"60","author":"Schreurs","year":"2000","journal-title":"Cancer Res"},{"key":"10.1038\/sj.mt.6300390_bib45","first-page":"253","article-title":"Genetic vaccination with \u201cself\u201d tyrosinase-related protein 2 causes melanoma eradication but not vitiligo","volume":"60","author":"Bronte","year":"2000","journal-title":"Cancer Res"},{"key":"10.1038\/sj.mt.6300390_bib46","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1096\/fj.05-4006fje","article-title":"Specificpharmacological dimerization of KDR in lentivirally transduced human hematopoietic cells activates anti-apoptotic and proliferative mechanisms","volume":"19","author":"Siatskas","year":"2005","journal-title":"FASEB J"},{"key":"10.1038\/sj.mt.6300390_bib47","doi-asserted-by":"crossref","first-page":"11382","DOI":"10.1073\/pnas.93.21.11382","article-title":"Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector","volume":"93","author":"Naldini","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.mt.6300390_bib48","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1089\/10430349950017293","article-title":"Circulating \u03b1-galactosidase Aderived from transduced bone marrow cells: relevance for corrective gene transfer for Fabry disease","volume":"10","author":"Takenaka","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1038\/sj.mt.6300390_bib49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0022-1759(01)00487-2","article-title":"Quantitative measurement of anti-ErbB-2 antibody by flow cytometry and ELISA","volume":"259","author":"Piechocki","year":"2002","journal-title":"J Immunol Methods"},{"key":"10.1038\/sj.mt.6300390_bib50","first-page":"17","article-title":"Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT","volume":"6","author":"Maecker","year":"2005","journal-title":"BMCImmunol"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616314368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616314368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T18:36:07Z","timestamp":1684175767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616314368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S1525001616314368"],"URL":"https:\/\/doi.org\/10.1038\/sj.mt.6300390","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}